{{Rsnum
|rsid=1051992
|Gene=PRKCDBP
|Chromosome=11
|position=6319476
|Orientation=minus
|GMAF=0.4665
|Gene_s=PRKCDBP
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 29.7 | 50.5 | 19.8
| HCB | 35.1 | 52.2 | 12.7
| JPT | 34.2 | 49.5 | 16.2
| YRI | 13.0 | 42.5 | 44.5
| ASW | 31.6 | 40.4 | 28.1
| CHB | 35.1 | 52.2 | 12.7
| CHD | 41.7 | 49.1 | 9.3
| GIH | 30.3 | 43.4 | 26.3
| LWK | 18.5 | 48.1 | 33.3
| MEX | 16.4 | 43.6 | 40.0
| MKK | 18.2 | 50.0 | 31.8
| TSI | 29.7 | 54.5 | 15.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23020606
|Title=Genetic Polymorphism of PRKCDBP is Associated With an Increased Risk of Endometrial Cancer
}}

{{GET Evidence
|gene=PRKCDBP
|aa_change=Leu158Pro
|aa_change_short=L158P
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1051992
|overall_frequency_n=5238
|overall_frequency_d=10736
|overall_frequency=0.487891
|n_genomes=38
|n_genomes_annotated=0
|n_haplomes=49
|n_articles=0
|n_articles_annotated=0
|nblosum100=7
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}